An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 205673
Company: STRIDES PHARMA

Products on ANDA 205673

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	5MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	AB	No	No
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	10MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	AB	No	No
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	15MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 205673

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/31/2017	ORIG-1	Approval		STANDARD		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
03/11/2024	SUPPL-3	Labeling-Medication Guide, Labeling-Package Insert		Label is not available on this site.
03/11/2024	SUPPL-2	Labeling-Package Insert		Label is not available on this site.

Therapeutic Equivalents for ANDA 205673

DEXTROAMPHETAMINE SULFATE

CAPSULE, EXTENDED RELEASE;ORAL; 5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DEXEDRINE	DEXTROAMPHETAMINE SULFATE	5MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	017078	IMPAX LABS INC
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	5MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	203901	ACTAVIS ELIZABETH
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	5MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	076353	SPECGX LLC
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	5MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	205673	STRIDES PHARMA

CAPSULE, EXTENDED RELEASE;ORAL; 10MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DEXEDRINE	DEXTROAMPHETAMINE SULFATE	10MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	017078	IMPAX LABS INC
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	10MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	203901	ACTAVIS ELIZABETH
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	10MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	076353	SPECGX LLC
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	10MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	205673	STRIDES PHARMA

CAPSULE, EXTENDED RELEASE;ORAL; 15MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DEXEDRINE	DEXTROAMPHETAMINE SULFATE	15MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	Yes	AB	017078	IMPAX LABS INC
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	15MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	203901	ACTAVIS ELIZABETH
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	15MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	076353	SPECGX LLC
DEXTROAMPHETAMINE SULFATE	DEXTROAMPHETAMINE SULFATE	15MG	CAPSULE, EXTENDED RELEASE;ORAL	Prescription	No	AB	205673	STRIDES PHARMA

Top